RAS Switch in Patients With Metastatic RAS Native Colorectal Tumors Treated With 1st Line FOLFIRI-Cetuximab
Clinical trial NCT01943786 · UNKNOWN
Trial details
- NCT number
- NCT01943786
- Sponsor
- Sofia Perea, Director Clinical Trials Unit.
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2013-04-01
- Primary completion
- 2015-04-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.